OCF sponsors oral cancer awareness month
The Oral Cancer Foundation (OCF) is sponsoring the 14th Annual Oral Cancer Awareness Month this April. The foundation is encouraging dental practices across the U.S.
The Oral Cancer Foundation (OCF) is sponsoring the 14th Annual Oral Cancer Awareness Month this April. The foundation is encouraging dental practices across the U.S.
Is there a direct relationship between oral leukoplakia and tobacco and alcohol consumption? Do all oral leukoplakias lead to oral squamous cell carcinoma (OSCC)? Is
U.K. children are being exposed to millions of tobacco images and messages every week on prime-time television, according to a new study in Tobacco Control
In a recent study, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center examined whether the addition of multiple drugs to radiation
A series of microRNA expression signatures may help predict the progression of Barrett’s esophagus into esophageal adenocarcinoma, according to a new study in Cancer Prevention
Millennium HealthCare has signed an exclusive nationwide distribution agreement for an oral cancer brush biopsy test. The noninvasive, in-office test can help ensure that harmless-appearing
Drinking tea and coffee may decrease the risk of oral cavity cancer through antioxidant components that aid in the repair of cellular damages, according to
A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival (Cancer, March 1,
Alcohol consumption causes approximately 20,000 cancer deaths in the U.S. annually, especially oral cavity cancer in men and breast cancer in women, according to a
The Head and Neck Cancer Alliance (HNCA) has launched a national video contest as a prelude to Oral, Head and Neck Cancer Awareness Week, April
A new study has confirmed the presence of four molecular classes of head and neck cancer (HNC), suggesting there may be an underlying connection between
Researchers have found promising results from a drug combination that appears to reduce the risk for patients with advanced oral precancerous lesions to develop squamous